Search research articles
Contact Us
Filters
Showing results (1-10 of 504) with videos related to
Page
of 51
Sort By:
Transfusion
|
July 11, 2022
Four decades of HIV and transfusion safety: Much accomplished but ongoing challenges
Michael P Busch
Transfusion
|
September 28, 2006
Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors
Michael P Busch
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
February 26, 2004
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Michael P Busch
Clinical Advances in Hematology & Oncology : H&O
|
September 28, 2016
Zika and the safety of the US blood supply
Michael P Busch
Transfusion
|
September 13, 2006
Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis
Michael P Busch
Antiviral Therapy
|
January 17, 2013
Transfusion transmission of HCV, a long but successful road map to safety
Suganya Selvarajah, Michael P Busch
Blood Transfusion = Trasfusione Del Sangue
|
June 12, 2019
Diversity in a blood bag: application of omics technologies to inform precision Transfusion Medicine
Tamir Kanias, Michael P Busch,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 27, 2021
Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations
Michael P Busch, Mars Stone
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 13, 2006
Assessing the impact of HBV NAT on window period reduction and residual risk
Steven H Kleinman, Michael P Busch
Transfusion
|
September 11, 2013
Herbert Asa Perkins, MD
Michael P Busch, Paul M Ness
Page
of 51
Search research articles
Search
Showing results (1-10 of 504) with videos related to
Sort By:
Page
of 51
Transfusion
|
July 11, 2022
Four decades of HIV and transfusion safety: Much accomplished but ongoing challenges
Michael P Busch
Transfusion
|
September 28, 2006
Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors
Michael P Busch
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
February 26, 2004
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Michael P Busch
Clinical Advances in Hematology & Oncology : H&O
|
September 28, 2016
Zika and the safety of the US blood supply
Michael P Busch
Transfusion
|
September 13, 2006
Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis
Michael P Busch
Antiviral Therapy
|
January 17, 2013
Transfusion transmission of HCV, a long but successful road map to safety
Suganya Selvarajah, Michael P Busch
Blood Transfusion = Trasfusione Del Sangue
|
June 12, 2019
Diversity in a blood bag: application of omics technologies to inform precision Transfusion Medicine
Tamir Kanias, Michael P Busch,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 27, 2021
Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations
Michael P Busch, Mars Stone
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 13, 2006
Assessing the impact of HBV NAT on window period reduction and residual risk
Steven H Kleinman, Michael P Busch
Transfusion
|
September 11, 2013
Herbert Asa Perkins, MD
Michael P Busch, Paul M Ness
Page
of 51